Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Robert Michael to succeed Gonzalez as Abbvie’s chair

Plus: Olazábal leaving Ysios and updates from Augustine and Prolific

February 15, 2025 1:53 AM UTC

Abbvie Inc. (NYSE:ABBV) CEO Robert Michael will succeed Richard Gonzalez as chairman on July 1. Gonzalez, who is retiring, became Abbvie’s chairman and CEO in 2013, handing off the CEO role to Michael last year. 

Paula Olazábal is leaving Ysios Capital. Olazábal joined the European VC as an investment manager in 2008 and became partner in 2019. She’s yet to disclose her next adventure...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article